lentinan has been researched along with Bladder Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, M; Wu, B; Xie, Q; Zhan, Y; Zhao, W | 1 |
| B, A; Bao, L; Cheng, R; Ma, R; Ren, X; Wang, Y | 1 |
| Akuzawa, Y; Endo, F; Kurashige, S | 1 |
1 review(s) available for lentinan and Bladder Cancer
| Article | Year |
|---|---|
Lentinan reduces tumor progression by enhancing gemcitabine chemotherapy in urothelial bladder cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Deoxycytidine; Enzyme-Linked Immunosorbent Assay; Gemcitabine; Humans; Lentinan; Urinary Bladder Neoplasms; Urothelium | 2015 |
2 other study(ies) available for lentinan and Bladder Cancer
| Article | Year |
|---|---|
Apoptosis-inducing effects of lentinan on the proliferation of human bladder cancer T24 cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Lentinan; Membrane Potential, Mitochondrial; Reactive Oxygen Species; Urinary Bladder Neoplasms | 2015 |
Effects of Lentinus edodes, Grifola frondosa and Pleurotus ostreatus administration on cancer outbreak, and activities of macrophages and lymphocytes in mice treated with a carcinogen, N-butyl-N-butanolnitrosoamine.
Topics: Animals; Antibiotics, Antineoplastic; Basidiomycota; beta-Glucans; Butylhydroxybutylnitrosamine; Carcinogens; Cells, Cultured; Chemotaxis; Concanavalin A; Cytotoxicity, Immunologic; Disease Outbreaks; Eating; Female; Glucans; Lentinan; Lymphocyte Activation; Lymphocytes; Macrophages; Medicine, Traditional; Mice; Mice, Inbred ICR; Neoplasms; Polyporaceae; Polysaccharides; Spleen; Urinary Bladder Neoplasms | 1997 |